The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and β-Secretase β-Site APP-Cleaving Enzyme
Abstract
sorLA is a recently identified neuronal receptor for amyloid precursor protein (APP) that is known to interact with APP and affect its intracellular transport and processing. Decreased levels of sorLA in the brain of Alzheimer's disease (AD) patients and elevated levels of amyloid-β peptide (Aβ) in sorLA-deficient mice point to the importance of the receptor in this neurodegenerative disorder. We analyzed APP cleavage in an APP-shedding assay and found that both sorLA and, surprisingly, a sorLA tail construct inhibited APP cleavage in a β-site APP-cleaving enzyme (BACE)-dependent manner. In line with this finding, sorLA and the sorLA tail significantly reduced secreted Aβ levels when BACE was overexpressed, suggesting that sorLA influencesβ-cleavage. To understand the effect of sorLA on APP cleavage by BACE, we analyzed whether sorLA interacts with APP and/or BACE. Because both full-length sorLA and sorLA C-terminal tail constructs were functionally relevant for APP processing, we analyzed sorLA–APP for a potential cytoplasmatic interaction domain. sorLA and C99 coimmunoprecipitated, pointing toward the existence of a new cytoplasmatic interaction site between sorLA and APP. Moreover, sorLA and BACE also coimmunoprecipitate. Thus, sorLA interacts both with BACE and APP and might therefore directly affect BACE–APP complex formation. To test whether sorLA impacts BACE–APP interactions, we used a fluorescence resonance energy transfer assay to evaluate BACE–APP interactions in cells. We discovered that sorLA significantly reduced BACE–APP interactions in Golgi. We postulate that sorLA acts as a trafficking receptor that prevents BACE–APP interactions and hence BACE cleavage of APP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SORLA reduces APP and BACE1 interactions while directly binding and facilitating Aβ internalization and lysosomal degradation.
“In addition, SORLA reduces APP and BACE1 (Spoelgen, von Arnim et al. 2006) interactions while directly binding and facilitating Aβ internalization and lysosomal degradation (Caglayan, Takagi-Niidome et al. 2014, Liu, Zhu et al. 2020).”
From SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain (2026) · cites this paper as Spoelgen, von Arnim et al. 2006
LR11/SorLA interacts with APP and affects its subcellular localization and proteolytic processing.
“It was demonstrated that LR11/SorLA interacts with APP and affects its subcellular localization and proteolytic processing (Andersen et al., 2006;Offe et al., 2006;Spoelgen et al., 2006).”
From GGA1 Is Expressed in the Human Brain and Affects the Generation of Amyloid β-Peptide (2006) · cites this paper as Spoelgen et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 2×
“…the amyloid precursor protein (APP) by sequential proteolysis by -secretase -site of APP-cleaving enzyme (BACE) and presenilin 1 (PS1) (Hussain et al., 1999; Sinha et al., 1999; Vassar et al., 1999; Wolfe et al., 1999; Yan et al., 1999; Lin et al., 2000; Xia et al., 2000; Wolfe and Kopan, 2004).”
BackgroundResultScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
GLIEMANN, J., HERMEY, G., NYKJÆR, A., PETERSEN, C. M., JACOBSEN, C., & ANDREASEN, P. A. (2004) · Biochemical Journal · doi:10.1042/bj20040149 · Cited by 58
Flagged first, then by citations
Research works printed but not linked: 40
- 10.1073/pnas.0503689102 · DOI · Paper page
- 10.1117/1.1584442 · DOI
- 2003, Sci Aging Knowledge Environ, 2003, PE14
- 10.1083/jcb.138.3.671 · DOI
- 10.1038/nm0997-1021 · DOI
- 10.1097/00001756-199909290-00017 · DOI
- 10.1001/archneur.60.7.958 · DOI
- 10.1038/357500a0 · DOI
- 10.1038/nm0997-1016 · DOI
- 10.1074/jbc.M411296200 · DOI
- 10.1074/jbc.M004175200 · DOI · Paper page
- 10.1006/mcne.1999.0811 · DOI · Paper page
- 10.1111/j.1471-4159.2004.02581.x · DOI · Paper page
- 10.1074/jbc.M100857200 · DOI · Paper page
- 10.1016/S0014-5793(01)03299-9 · DOI
- 2001, J Neurosci, 21, 8354, 10.1523/JNEUROSCI.21-21-08354.2001 · DOI · Paper page
- 10.1074/jbc.M306403200 · DOI · Paper page
- 1994, J Biol Chem, 269, 17386, 10.1016/S0021-9258(17)32449-3 · DOI · Paper page
- 1996, J Cell Sci, 109, 991, 10.1242/jcs.109.5.991 · DOI
- 1997, Neurology, 48, 741, 10.1212/WNL.48.3.741 · DOI
- 1993, Biochem J, 295, 367, 10.1042/bj2950367 · DOI
- 10.1074/jbc.270.8.3565 · DOI
- 10.1074/jbc.M303861200 · DOI · Paper page
- 10.1073/pnas.97.4.1456 · DOI
- 10.1074/jbc.271.15.9100 · DOI
- 10.1016/S0092-8674(01)00299-9 · DOI
- 10.1001/archneur.61.8.1200 · DOI · Paper page
- 2001, Physiol Rev, 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
- 10.1111/j.1600-0854.2004.00188.x · DOI · Paper page
- 10.1073/pnas.96.20.11049 · DOI
- 10.1038/990114 · DOI · Paper page
- 10.1161/hq0901.094500 · DOI
- 10.1074/jbc.C100218200 · DOI
- 10.1242/jcs.01422 · DOI · Paper page
- 10.1126/science.1096187 · DOI
- 10.1038/19077 · DOI
- 10.1073/pnas.97.16.9299 · DOI
- 10.1074/jbc.271.40.24761 · DOI
- 10.1038/990107 · DOI · Paper page
- 10.1126/science.1060896 · DOI · Paper page
Cited by
Sorted by citations
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
The Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546
Alzheimer’s Disease Genetics: From the Bench to the Clinic
Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473
Dodson, S. E., Andersen, O. M., Karmali, V., Fritz, J. J., Cheng, D., Peng, J., Levey, A. I., Willnow, T. E., & Lah, J. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4582-08.2008 · Cited by 141
Self-citationMarzolo, M.-P., & Bu, G. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.10.005 · Cited by 122
Proteomic identification of sorting nexin 6 as a negative regulator of BACE1‐mediated APP processing
Okada, H., Zhang, W., Peterhoff, C., Hwang, J. C., Nixon, R. A., Ryu, S. H., & Kim, T. (2010) · The FASEB Journal · doi:10.1096/fj.09-146357 · Cited by 102
GGA1 Is Expressed in the Human Brain and Affects the Generation of Amyloid β-Peptide
Wahle, T., Thal, D. R., Sastre, M., Rentmeister, A., Bogdanovic, N., Famulok, M., Heneka, M. T., & Walter, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1982-06.2006 · Cited by 88
Fuentealba, R. A., Barría, M. I., Lee, J., Cam, J., Araya, C., Escudero, C. A., Inestrosa, N. C., Bronfman, F. C., Bu, G., & Marzolo, M.-P. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-14 · Cited by 70
Huang, T. Y., Zhao, Y., Li, X., Wang, X., Tseng, I.-C., Thompson, R., Tu, S., Willnow, T. E., Zhang, Y.-W., & Xu, H. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0206-16.2016 · Cited by 69
Self-citationFE65 interaction with the ApoE receptor ApoEr2
Hoe, H.-S., Magill, L. A., Guenette, S., Fu, Z., Vicini, S., & Rebeck, G. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600728200 · Cited by 69
The generation and function of soluble apoE receptors in the CNS
Rebeck, G. W., LaDu, M. J., Estus, S., Bu, G., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-15 · Cited by 66
SORLA attenuates EphA4 signaling and amyloid β–induced neurodegeneration
Huang, T. Y., Zhao, Y., Jiang, L.-L., Li, X., Liu, Y., Sun, Y., Piña-Crespo, J. C., Zhu, B., Masliah, E., Willnow, T. E., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171413 · Cited by 50
Self-citationSORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain
Huang, H., Shi, C. H., Yang, W., Piña-Crespo, J. C., Bhatnagar, J., Curatolo, J., Murad, R., Shah, P., Campos, A., Houser, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed6825 · Cited by 1
Metadata
- Authors
- Spoelgen, R., von Arnim, C. A. F., Thomas, A. V., Peltan, I. D., Koker, M., Deng, A., Irizarry, M. C., Andersen, O. M., Willnow, T. E., & Hyman, B. T.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-01-11
- Volume
- 26
- Issue
- 2
- Pages
- 418-428
- ISSN
- 0270-6474
- 1529-2401
- Cited by
- 148
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review